×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)

NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)

货号:CL-0178

规格:1×10⁶cells/T25培养瓶

价格: ¥2000

生长培养基:RPMI-164020% FBS10μg/mL Insulin1% P/S

数量: - +

  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
  • NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确) ¥2000

细胞培养最优解!

套餐组合价:¥2750¥2850

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 NIH:OVCAR-3 [OVCAR3] (人卵巢癌细胞) (STR鉴定正确)
别称 Ovcar-3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR.3; OVCAR3; Ovcar3
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 NIH:OVCAR-3 [OVCAR3]细胞是由T·C·Hamilton在1982年建系,NIH:OVCAR-3 [OVCAR3]细胞取材于患进行性卵巢腺癌病人的恶性腹水。在裸鼠皮下接种 1×10^7细胞,21天后全部成瘤。NIH:OVCAR-3 [OVCAR3]细胞是研究卵巢癌药物抗性的一个合适的模型系统且由于存在激素受体,这对于激素治疗的评估或许是有用的。
年龄(性别) 女性;60岁
组织来源 卵巢腺癌
细胞类型 肿瘤细胞
肿瘤类型 卵巢癌细胞
生物安全等级 BSL-1
倍增时间 ~35-64 hours
致瘤性 Yes, Forms colonies in soft agar.Yes, in nude mice inoculated subcutaneously with 1×10^7 cells (Tumors developed within 21 days at 100% frequency (5/5)).
受体表达情况 Androgen receptor, positive;estrogen receptor, positive;progesterone receptor, positive
保藏机构 ATCC; HTB-161
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11,12
    D2S1338 17,21
    D3S1358 17,18
    D5S818 11,12
    D7S820 10
    D8S1179 10,15
    D13S317 12
    D16S539 12
    D18S51 13
    D19S433 14,16.2
    D21S11 29,31.2
    FGA 21
    PentaD 12,13
    PentaE 7,13
    TH01 9
    TPOX 8
    vWA 17
    D6S1043 10,11
    D12S391 19,22
    D2S441 11,14
  • STR鉴定图
参考文献
文献列表
  • Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer (2024-02-26)

    作者:Weisong Li:1.Department of Pathology, First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, China. ; 2.Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Gannan Medical University, 1 Hexie Road, Rongjiang New District, Ganzhou, 341000, China. ; Kai Zhang:1.Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Gannan Medical University, 1 Hexie Road, Rongjiang New District, Ganzhou, 341000, China. ; 2.School of Basic Medicine, Gannan Medical University, Ganzhou, 341000, China. ; Wenjun Wang:1.Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Gannan Medical University, 1 Hexie Road, Rongjiang New District, Ganzhou, 341000, China. ; 2.Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. ; Yuanyuan Liu:1.Department of Gynaecology and

    期刊:Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer

    DOI:10.1186/s13046-024-02981-5

    影响因子 :11.3

    引用产品: NIH:OVCAR-3 [OVCAR3] 细胞 ,  SK-OV-3 细胞 ,  McCoy's 5A 培养基

  • m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway (2024-01-29)

    作者:Yan Li:1.Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, 150007, Heilongjiang, China. ; 2.Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin, 150081, Heilongjiang, China. ; Shenghan Lou:1.Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin, 150081, Heilongjiang, China. ; Jian Zhang:1.Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin, 150081, Heilongjiang, China. ; Shilu Zhao:1.Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin, 150081, Heilongjiang, China. ; Ge Lou:1.Department of Gynecology, Harbin Medical University Cancer Hospital, 150 HaPing Road, Nangang District, Harbin, 150081, Heilongjiang, China. louge@ems.hrbmu.edu.cn. ;

    期刊:m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway

    DOI:10.1186/s12967-024-04929-x

    影响因子 :7.4

    引用产品: A2780 细胞 ,  Caov-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  SK-OV-3 细胞 ,  IOSE80 细胞

  • Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53 (2024-02-04)

    作者:Zhaofeng Liu:1.School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China. ; Yifei Yang:1.School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China. ; Xiaohui Sun:1.School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China. ; Runchen Ma:1.School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery

    期刊:Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53

    DOI:10.3390/molecules29030725

    影响因子 :4.6

    引用产品: NIH:OVCAR-3 [OVCAR3] 细胞

  • CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells (2024-03-27)

    作者:Qingsong Zhang:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou, 215006, Jiangsu, People's Republic of China. ; Rong Zhang:1.Department of Gynecological Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233004, Anhui, China. ; Yuzhi Li:1.Department of Gynecological Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233004, Anhui, China. ; Xiaojun Yang:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou, 215006, Jiangsu, People's Republic of China. Yang.Xiaojun@hotmail.com. ;

    期刊:CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells

    DOI:10.1186/s13048-024-01393-5

    影响因子 :4.0

    引用产品: Annexin V Binding Buffer (1×) ,  SK-OV-3 细胞 ,  Hey 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  A2780 细胞 ,  ES-2 细胞 ,  HO-8910 细胞 ,  IOSE-80 细胞

  • MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo (2024-01-08)

    作者:Yun Zhang:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China; Liaoning Key Laboratory of Follicular Development and Reproductive Health, Jinzhou, Liaoning, China. Electronic address: sparkice818@163.com. ; Fanglin Liu:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. Electronic address: 1960133759@qq.com. ; Jindan Zheng:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. Electronic address: zhengjindan@yeah.net. ; Keping Jiang:1.Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. Electronic address: bsbjkp@hotmail.com. ; Hao Ai:1.Liaoning Key Laboratory of Follicular Development and Reproductive Health, Jinzhou, Liaoning, China; Department of Obstetrics and Gynecology, The Th

    期刊:MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo

    DOI:10.1016/j.yexcr.2024.113913

    影响因子 :3.7

    引用产品: Anglne 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression (2023-10-12)

    作者:Yanan Pi:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Qiushi Feng:1.Heilongjiang Academy of Chinese Medical Sciences, Harbin, 150036, P. R. China. ; Fusheng Sun:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Zhiqiang Wang:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Yue Zhao:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Dejia Chen:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Yiming Liu:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. ; Ge Lou:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150086, P. R. China. louge@ems.hrbmu.edu.cn. ;

    期刊:Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression

    DOI:10.1038/s41418-023-01226-w

    影响因子 :12.4

    引用产品: 293T [HEK-293T] 细胞 ,  SK-OV-3 细胞 ,  Caov-3 细胞 ,  A2780 细胞 ,  Hey 细胞 ,  SW626 细胞 ,  Anglne 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM) (2023-04-22)

    作者:Yaoyun Duan:1.Division of Uterine Vascular Biology, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 510623, Guangzhou, China. ; Juan Yu:1.Division of Uterine Vascular Biology, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 510623, Guangzhou, China. ; Miaojuan Chen:1.Division of Uterine Vascular Biology, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 510623, Guangzhou, China. ; Qinsheng Lu:1.Division of Uterine Vascular Biology, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 510

    期刊:Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)

    DOI:10.1186/s13048-023-01156-8

    影响因子 :4.0

    引用产品: SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  ES-2 细胞 ,  A2780 细胞

  • Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives (2023-11-27)

    作者:Yan Li:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. ; 2.Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. ; Liang Meng:1.State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. ; Ge Lou:1.Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. ;

    期刊:Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives

    DOI:10.1080/15384047.2023.2285817

    影响因子 :3.6

    引用产品: A2780 细胞 ,  Caov-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  SK-OV-3 细胞 ,  IOSE80 细胞

  • ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer (2023-11-03)

    作者:Yue Deng:1.Department of Gynecology,The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China. ; Ying Dong:1.Department of Gynecology,The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China. ; Lu Wu:1.Department of Gynecology,The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China. ; Qin Zhang:1.Department of Gynecology,The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China. ; Lihua Yang:1.Department of Gynecology,The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, China. Electronic address: lihuazhang33@sina.com. ;

    期刊:ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer

    DOI:10.1016/j.prp.2023.154911

    影响因子 :2.8

    引用产品: A2780 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3 (2023-02-01)

    作者:Chenggan Shu:1.Department of Gynecology, The First People's Hospital of Yancheng, City, Yancheng 224006, P.R. China. ; 2.Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, 200065, P.R. China. ; Weiwei Wang:1.Department of Pathology, Tinghu People's Hospital, Yancheng, 224001, P.R. China. ; Lipei Wu:1.Department of Laboratory Medicine, Dongtai People's Hospital & Dongtai Hospital of Nantong University, Yancheng, 224200, P.R. China. ; Chunrun Qi:1.Department of Pathology, Tinghu People's Hospital, Yancheng, 224001, P.R. China. ; Wenhui Yan:1.Department of Laboratory Medicine, Tinghu People's Hospital, Yancheng, 224001, P.R. China. ; Wenying Lu:1.Department of Laboratory Medicine, Tinghu People's Hospital, Yancheng, 224001, P.R. China. ; Jiale Tian:1.Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, 200065, P.R. China. ; Anquan Shang:1.Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, 200065, P.R. China. ;

    期刊:LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3

    DOI:10.2174/1574892817666220316152201

    影响因子 :2.8

    引用产品: SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  A2780 细胞 ,  HO-8910 细胞 ,  人卵巢上皮细胞

  • circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis (2022-10-22)

    作者:Huiping Ma:1.Department of Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710000, Shaanxi, China. ; Shuyun Qu:1.Department of Gynecology, Gynaecology Hospital of Shaanxi Nuclear Industry, Xi'an, Shaanxi, China. ; Yao Zhai:1.Department of Gynecology, Gynaecology Hospital of Shaanxi Nuclear Industry, Xi'an, Shaanxi, China. ; Xiaofeng Yang:1.Department of Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710000, Shaanxi, China. yangxf73@126.com. ;

    期刊:circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis

    DOI:10.1186/s11658-022-00364-2

    影响因子 :8.7

    引用产品: Hey 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  人脐静脉内皮细胞 ,  人脐静脉内皮细胞完全培养基

  • PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib (2022-09-05)

    作者:Xiaocui Zhang:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. ; Meige Sun:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. ; Yisheng Jiao:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. ; Bei Lin:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. ; Qing Yang:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. ;

    期刊:PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib

    DOI:10.1155/2022/9029544

    影响因子 :7.3

    引用产品: A2780 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  ES-2 细胞 ,  RPMI-1640 培养基 ,  特级胎牛血清 ,  McCoy's 5A 培养基 ,  增强型细胞活力检测试剂盒 (CCK-8) ,  碘化丙啶 (PI)染色液 (50μg/mL)

  • Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells (2022-08-25)

    作者:Xiaoyan Zhu:1.Department of Obstetrics and Gynecology, Jianhu Hospital Affiliated to Nantong University, Yancheng, Jiangsu 224700, P.R. China. ; Xiaohong Chen:1.Department of Gynecology, People's Hospital of Gansu Province, Lanzhou, Gansu 730000, P.R. China. ; Longshan Qiu:1.Department of Obstetrics and Gynecology, Jianhu Hospital Affiliated to Nantong University, Yancheng, Jiangsu 224700, P.R. China. ; Jianhua Zhu:1.Department of Obstetrics and Gynecology, Jianhu Hospital Affiliated to Nantong University, Yancheng, Jiangsu 224700, P.R. China. ; Jiancai Wang:1.Department of Obstetrics and Gynecology, Jianhu Hospital Affiliated to Nantong University, Yancheng, Jiangsu 224700, P.R. China. ;

    期刊:Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells

    DOI:10.3892/ol.2022.13479

    影响因子 :3.1

    引用产品: SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells (2022-12-05)

    作者:Lifang Liu:1.The Laboratory of Cell and Genetics, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Bingkai Han:1.Tianjin Key Laboratory of Exercise Physiology and Sports Medicine, College of Exercise and Health Sciences, Tianjin University of Sport, Tianjin City 301617, China. ; Lixia Liu:1.Department of Obstetrics and Gynecology, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Hongying Cui:1.Department of Obstetrics and Gynecology, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Hao Liu:1.The Laboratory of Cell and Genetics, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Rui Jia:1.Eproductive Center, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Xiaoyan Zhang:1.The Laboratory of Cell and Genetics, the People's Hospital of Hebi, 458030 Hebi City, Henan, China. ; Xiaoxiao Lu:1.Sumy National Agrarian University, Sumy City 40021, Ukraine. Electronic address: Lxxlxx5566@163.com. ;

    期刊:Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells

    DOI:10.1016/j.repbio.2022.100704

    影响因子 :2.1

    引用产品: SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  A2780 细胞 ,  ES-2 细胞 ,  293T [HEK-293T] 细胞 ,  RPMI-1640 培养基 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗),100×

  • Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression (2006-01-20)

    作者:Ting-Ting Gong:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Qian Guo:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Xiao Li:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Tie-Ning Zhang:1.Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Fang-Hua Liu:1.Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Xin-Hui He:1.Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. ; Bei Lin:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110004, Pe

    期刊:Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression

    DOI:10.1016/j.biopha.2021.111533

    影响因子 :7.5

    引用产品: CoC1 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  RPMI-1640 培养基 ,  McCoy's 5A 培养基

  • P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway (2008-01-20)

    作者:Limei Yan:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Zeping He:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Wei Li:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Ning Liu:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ; Song Gao:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. ;

    期刊:P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway

    DOI:10.1080/15384101.2021.1963910

    影响因子 :5.2

    引用产品: OV-90 细胞 ,  A2780 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  人卵巢上皮细胞 ,  NIH:OVCAR-3 [OVCAR3]细胞专用培养基 ,  人卵巢上皮细胞完全培养基 ,  OV-90细胞专用培养基

  • MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer (2004-01-20)

    作者:Mengqi Deng:1.Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. Electronic address: 122018000319@mail.ccmu.edu.cn. ; Di Wu:1.Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. Electronic address: wudi2022@ccmu.edu.cn. ; Yanqin Zhang:1.Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. Electronic address: 2270934602@qq.com. ; Zhaoyu Jin:1.National Center for Protein Science, Beijing, China. Electronic address: 18610630337@163.com. ; Jinwei Miao:1.Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. Electronic address: jinweimiao@ccmu.edu.cn. ;

    期刊:MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer

    DOI:10.1016/j.ygyno.2021.04.013

    影响因子 :4.7

    引用产品: A2780 细胞 ,  人卵巢上皮细胞 ,  SK-OV-3 细胞 ,  ES-2 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis (2008-01-20)

    作者:Wenwen Wang:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ; Weiwei Zhang:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ; Hongjun Guo:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ; Danxia Chu:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ; Ruitao Zhang:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ; Ruixia Guo:1.Department of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. ;

    期刊:CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis

    DOI:10.1080/15384101.2021.1965723

    影响因子 :4.3

    引用产品: A2780 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  SK-BR-3 [SKBR3] 细胞

  • Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP (2001-01-20)

    作者:Yinglei Liu:1.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nanjing Medical University, 262 Zhongshan North Road, Nanjing, 210000, China. ; 2.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nantong University, 6 Haierxiang North Road, Nantong, 226000, China. ; Boqun Xu:1.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nanjing Medical University, 262 Zhongshan North Road, Nanjing, 210000, China. ; Manhua Liu:1.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nantong University, 6 Haierxiang North Road, Nantong, 226000, China. ; Haifeng Qiao:1.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nantong University, 6 Haierxiang North Road, Nantong, 226000, China. ; Siming Zhang:1.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Nantong University, 6 Haierxiang North Road, Nantong, 226000, China. ; Junjun Qiu:1.Department of Gyne

    期刊:Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP

    DOI:10.7150/jca.47344

    影响因子 :3.9

    引用产品: A2780 细胞 ,  SK-OV-3 细胞 ,  Hey 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells (2009-01-20)

    作者:Li Ma:1.Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China. ; Wei Zhang:1.Department of Scientific Research, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710077, P.R. China. ; Yaofeng Jin:1.Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China. ; Xiaomei Bai:1.Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China. ; Qiaoling Yu:1.Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China. ;

    期刊:miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells

    DOI:10.3892/etm.2021.10754

    影响因子 :2.7

    引用产品: A2780 细胞 ,  ES-2 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  Caov-3 细胞

  • Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p (2002-00-20)

    作者:Hua Yang:1.Department of Ultrasound, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China. ; Yue Qi:1.Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, Liaoning, People's Republic of China. ; Xin-Lu Wang:1.Department of Ultrasound, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China. ; Jiao-Jiao Gu:1.Department of Ultrasound, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China. ; Tie-Mei Shi:1.Department of Ultrasound, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China. shitiemei1@126.com. ;

    期刊:Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p

    DOI:10.1007/s11010-020-03704-y

    影响因子 :4.3

    引用产品: ES-2 细胞 ,  McCoy's 5A 培养基 ,  NIH:OVCAR-3 [OVCAR3] 细胞

  • MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB (2010-09-20)

    作者:Zhen Zhang:1.Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China. ; Luoyan Zhang:1.Key Lab of Plant Stress Research, College of Life Science, Shandong Normal University, Jinan, 250014, Shandong, China. ; Bin Wang:1.Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. ; Ran Wei:1.Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China. ; Yunxia Wang:1.Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. ; Jipeng Wan:1.Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. ; Chi Zhang:1.Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. ; Lin

    期刊:MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB

    DOI:10.1016/j.canlet.2019.10.021

    影响因子 :9.7

    引用产品: A2780 细胞 ,  293T [HEK-293T] 细胞 ,  SK-OV-3 细胞 ,  NIH:OVCAR-3 [OVCAR3] 细胞 ,  ES-2 细胞

  • A 19F NMR probe for the detection of β-galactosidase: simple structure with low molecular weight of 274.2, “turn-on” signal without the background, and good performance applicable in cancer cell line (2006-07-20)

    作者:Jie Hu:1.Department of Chemistry, Hubei Key Lab on Organic and Polymeric Opto-Electronic Materials, Wuhan University, Wuhan 430072, China. lizhen@whu.edu.cn. ; Qiong Wu: Kai Cheng: Yujun Xie: Conggang Li: Zhen Li:

    期刊:A 19F NMR probe for the detection of β-galactosidase: simple structure with low molecular weight of 274.2, “turn-on” signal without the background, and good performance applicable in cancer cell line

    DOI:10.1039/c7tb00616k

    影响因子 :7.6

    引用产品: NIH:OVCAR-3 [OVCAR3] 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号